Characterization of Gas6, a member of the superfamily of G domain-containing proteins, as a ligand for Rse and Axl
about
Androgen receptor-dependent transactivation of growth arrest-specific gene 6 mediates inhibitory effects of testosterone on vascular calcificationThe role of gamma-carboxylation in the anti-apoptotic function of gas6Structural basis for Gas6-Axl signalling.Primary structure and tissue distribution of two novel proline-rich gamma-carboxyglutamic acid proteinsCrystal structure of human sex hormone-binding globulin: steroid transport by a laminin G-like domainAXL kinase as a novel target for cancer therapySteroid-binding specificity of human sex hormone-binding globulin is influenced by occupancy of a zinc-binding siteCrystal structure of a C-terminal fragment of growth arrest-specific protein Gas6. Receptor tyrosine kinase activation by laminin G-like domainsLigand recognition and homophilic interactions in Tyro3: structural insights into the Axl/Tyro3 receptor tyrosine kinase familyThe Receptor Tyrosine Kinase AXL in Cancer ProgressionLigand Activation of TAM Family Receptors-Implications for Tumor Biology and Therapeutic ResponseRole of Gas6 receptors in platelet signaling during thrombus stabilization and implications for antithrombotic therapySCF, BDNF, and Gas6 are regulators of growth plate chondrocyte proliferation and differentiation.GAS6 enhances repair following cuprizone-induced demyelination.Prediction of solution structures of the Ca2+-bound gamma-carboxyglutamic acid domains of protein S and homolog growth arrest specific protein 6: use of the particle mesh Ewald methodSex hormone binding globulins and atherosclerotic risk in systemic lupus.Gas6 induces growth, beta-catenin stabilization, and T-cell factor transcriptional activation in contact-inhibited C57 mammary cells.Overexpression of MERTK receptor tyrosine kinase in epithelial cancer cells drives efferocytosis in a gain-of-function capacity.Regulation of phagocytosis by TAM receptors and their ligands.The physiology of vitamin K nutriture and vitamin K-dependent protein function in atherosclerosis.Differential TAM receptor-ligand-phospholipid interactions delimit differential TAM bioactivities.Identification and tissue expression of a splice variant for the growth arrest-specific gene gas6.The product of a gas6 splice variant allows the release of the domain responsible for Axl tyrosine kinase receptor activation.TAM receptor tyrosine kinases: biologic functions, signaling, and potential therapeutic targeting in human cancer.Inactivation of GSK3β and activation of NF-κB pathway via Axl represents an important mediator of tumorigenesis in esophageal squamous cell carcinoma.Hematopoietic progenitor cells grow on 3T3 fibroblast monolayers that overexpress growth arrest-specific gene-6 (GAS6).A soluble form of the Mer receptor tyrosine kinase inhibits macrophage clearance of apoptotic cells and platelet aggregation.Expression of receptor tyrosine kinase Axl and its ligand Gas6 in rheumatoid arthritis: evidence for a novel endothelial cell survival pathway.The TAM-family receptor Mer mediates production of HGF through the RhoA-dependent pathway in response to apoptotic cellsLocalization and signaling of the receptor protein tyrosine kinase Tyro3 in cortical and hippocampal neurons.Targeting Axl with an high-affinity inhibitory aptamer.Direct demonstration of MuSK involvement in acetylcholine receptor clustering through identification of agonist ScFv.Histone modifications and p53 binding poise the p21 promoter for activation in human embryonic stem cellsA prognostic risk model for patients with triple negative breast cancer based on stromal natural killer cells, tumor-associated macrophages and growth-arrest specific protein 6.Normalization of TAM post-receptor signaling reveals a cell invasive signature for Axl tyrosine kinase.Mer tyrosine kinase (MerTK) promotes macrophage survival following exposure to oxidative stress.Biology of the TAM receptors.A novel role for vitamin K1 in a tyrosine phosphorylation cascade during chick embryogenesis.A genomic screen identifies TYRO3 as a MITF regulator in melanoma.The receptor AXL diversifies EGFR signaling and limits the response to EGFR-targeted inhibitors in triple-negative breast cancer cells.
P2860
Q24293731-E93DB61C-F94D-4BB1-948F-83EFFA91258EQ24299092-4D02D194-7EB2-4DFB-96B4-D662EC554CE6Q24299209-CAD999D6-97B4-41E8-AF5A-24DA504F28D4Q24322757-0842DB84-1975-4EB7-AA09-93E049C49ABFQ24601344-F7CE3B3C-F1D1-4684-BEBB-7C73B3DA232CQ26863442-7CA15E38-89A6-444C-A5A2-F2AB79C35646Q27624951-641084C1-E976-4432-B11F-41B240C3D2A0Q27639609-96F7DB66-9703-4BF4-AECA-DC1322CB3561Q27642567-4B22D11A-57CB-4A2F-B4C8-CF3153C4A0A9Q28068756-F4A3082C-3FAF-4E3A-902D-2291A7A1782EQ28072503-89406273-58DF-49F4-8282-D30D1283F0B8Q28584706-FDE93689-5AEF-402F-937F-E7A8E204E06EQ33576515-4EEF4F32-D65A-4399-9615-6ED28E563BFDQ33784396-1BF0DFD2-698B-404E-B12F-5B1F576E12E6Q33907547-4C01F177-135C-4748-BA4F-BC23228C263DQ33915472-869AEF5D-5E09-4AEF-86A2-75711E29E422Q33967129-7372AAD0-26A3-4097-9E8E-270DB133A002Q34170756-4D73C158-2F8C-4FE7-9B9C-D27506CA8BF2Q34271347-C0008C2D-9003-4F54-B068-8F254DD557D0Q34378782-EA4F7C88-0C9B-4BC2-B9BC-E5AB395C0855Q34390266-0B321823-E579-4595-96D2-10597DD9E809Q34441778-81AC0961-7EAA-452F-BF2C-4173040023ABQ34441784-95612C83-34A2-4C54-9FC8-798642957750Q34794927-357B7A57-F2D6-4E3B-B4ED-8FDC315C5F33Q35125173-035A3660-1D9B-435D-B2C2-A1EF01911331Q35417117-A79CF467-FA78-43B9-8BD7-6EAD39041911Q35616136-CB7CAACD-8D2C-4726-A335-86B27AE0A055Q35786887-6D624CF0-9628-4F3B-8B1F-3AFBB2AEB527Q36161704-0EDFEACA-C513-48B5-9B90-46D67BCD1226Q36439979-EAC9215D-70B1-4D38-9AE6-2EFD42801DABQ36460465-397D4E9E-6A66-4127-A133-111EBE947993Q36876183-B12AD464-8F35-44CA-AB6C-B4B226ADD477Q37039808-537B25F3-7A34-4B6B-9B08-8FD247C0C97AQ37098286-2B04C2B8-5144-4DFA-8080-0D7E3EC9EC2BQ37233198-54C14D55-595D-40A3-8297-1474820CB16DQ37247570-A3294B10-B592-49CC-A698-38C71025B4B4Q37258717-5D6CC1B1-6D62-4AC5-B69A-AEED80C5D4E5Q37363242-1CC18822-BD8A-4339-8F43-35CEF4FDEC58Q37386014-88F47DCA-36D2-4653-9334-25AC32C6BEAFQ37627397-B92040F7-0FA2-40EA-93D4-47C1000D136A
P2860
Characterization of Gas6, a member of the superfamily of G domain-containing proteins, as a ligand for Rse and Axl
description
1996 nî lūn-bûn
@nan
1996 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
1996 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
name
Characterization of Gas6, a me ...... s, as a ligand for Rse and Axl
@ast
Characterization of Gas6, a me ...... s, as a ligand for Rse and Axl
@en
Characterization of Gas6, a me ...... s, as a ligand for Rse and Axl
@nl
type
label
Characterization of Gas6, a me ...... s, as a ligand for Rse and Axl
@ast
Characterization of Gas6, a me ...... s, as a ligand for Rse and Axl
@en
Characterization of Gas6, a me ...... s, as a ligand for Rse and Axl
@nl
prefLabel
Characterization of Gas6, a me ...... s, as a ligand for Rse and Axl
@ast
Characterization of Gas6, a me ...... s, as a ligand for Rse and Axl
@en
Characterization of Gas6, a me ...... s, as a ligand for Rse and Axl
@nl
P2093
P2860
P3181
P356
P1476
Characterization of Gas6, a me ...... s, as a ligand for Rse and Axl
@en
P2093
P2860
P304
P3181
P356
10.1074/JBC.271.16.9785
P407
P577
1996-04-19T00:00:00Z